首页> 外文期刊>Internal medicine. >Emergence of Carbapenem Non-susceptible Campylobacter coli after Long-term Treatment against Recurrent Bacteremia in a Patient with X-linked Agammaglobulinemia
【24h】

Emergence of Carbapenem Non-susceptible Campylobacter coli after Long-term Treatment against Recurrent Bacteremia in a Patient with X-linked Agammaglobulinemia

机译:X型X型激动蛋白血症患者的长期治疗后鲤鱼蛋白患者患者经济型菌血症后的出现

获取原文
获取外文期刊封面目录资料

摘要

We herein report a case of recurrent Campylobacter coli bacteremia in a 37-year-old Japanese man with X-linked agammaglobulinemia (XLA). The patient experienced seven episodes of C. coli bacteremia over one year, with an erythematous rash intermittently emerged on the lower limbs. Although hospitalization for intravenous treatment was repeatedly recommended, he obstinately declined it. Following long-term oral antibiotic treatment with tebipenem and faropenem for the persistent infection, C. coli showed elevated minimum inhibitory concentrations to meropenem, a key drug for severe campylobacteriosis. Physicians should note that the overuse of antibiotics can lead to the emergence of carbapenem-non-susceptible Campylobacter strains.
机译:我们在此报告了一个具有X-Linked Agammagloblobulinemia(XLA)的37岁的日本人复发弯曲杆菌菌血症的情况。患者经历了一年多的C. Coli菌血症的七集,在下肢中间歇性地出现了红斑狼疮。虽然重复推荐为静脉治疗住院治疗,但他顽固地拒绝了它。在与Tebipenem和Faropenem进行持续感染的长期口服抗生素治疗后,C.Coli表现出对Meropenem的最低抑制浓度升高,这是一个严重振动杆菌的关键药物。医生应注意,过度使用抗生素可能导致碳癌烯类 - 不敏感的弯曲杆菌菌株的出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号